Home Blog Page 2071

Australian employees call for structural change amid mental distress in the workplace

  • New research from Allianz Australia reveals nearly six in ten of surveyed Australian employees have experienced mental distress as a result of factors like workload pressure, meetings overload, and unrealistic deadlines.
  • Allianz Primary Psychological Workers Compensation claims have surged by 28.4 per cent between FY21 to FY25, with 2.73 million Australians likely to consider leaving their job within the next year.
  • Surveyed Australian employees are calling for better manager training to support employee wellbeing, fewer unnecessary tasks and recurring mental health days.
  • In response, Australian organisations are set to invest $33.83 billion in mental health support services this year.
  • Allianz is launching the “Unschedule the Burnout” hub, a suite of resources to support Australian workplaces and their employees to prevent burnout.   

SYDNEY, Oct. 21, 2025 /PRNewswire/ — New research from Allianz Australia reveals that supporting mental health in the workplace continues to be a challenge, as managers and employees alike are feeling mental distress as a result of workload.  

Almost 80 per cent of surveyed employees and almost two thirds of surveyed managers do not believe their organisation enforces good workplace habits and boundaries to reduce burnout. The majority of surveyed managers (78 per cent) cite systemic barriers to reducing burnout, ranging from a lack of time and resources (26 per cent) to the availability of suitable technology (26 per cent) and conflict with other workplace priorities (23 per cent). 

Nearly six in ten (59 per cent) surveyed employees stated they have experienced work-related mental distress, with workload pressure, meeting overload, and unrealistic deadlines the leading contributors. The average Australian employee reports spending 3.31 hours per week on tasks or meetings deemed unnecessary and nearly a third (32 per cent) felt unable to take proper breaks due to their back-to-back schedules.  

Beyond the workplace, 19 per cent of surveyed employees said technology made it difficult to switch off from work. One in four employees also report that their cost of living worries and financial pressures affect their ability to focus at work.

The research also reveals that 2.73 million Australians are considering leaving their jobs within the next year.

Concerns around work-related mental distress are reflected in a relative increase of 28.4 per cent in Allianz Primary Psychological Workers Compensation claims between FY21 and FY25, alongside a 10 per cent rise in the average time off per claim; jumping to 81 days.  

Mark Pittman, Executive General Manager – Personal Injury, Allianz Australia says, “Our claims data tells us that mental stress and work pressure is the second highest contributor of primary active psychological claims (34%). We are all on a journey and everyday we are learning more and more about supporting mental health in the workplace. While Allianz works to support injured workers who have been harmed by workplace stress, we recognise that the best outcomes are achieved through prevention. Through our insights, guides and other resources, we hope to positively contribute to creating more mentally healthy workplaces.”  

Unschedule the Burnout 

Allianz’s research, now in its seventh year, identifies opportunities for workplaces to “Unschedule the Burnout” in order to support the mental health of their workforce.  

To support organisations, Allianz has released a series of tailored resources, including video tutorials and comprehensive guidelines for the construction, education, healthcare and professional services industries to help prevent burnout across their workforce. Given the surveyed employee feedback that external pressures affect their ability to focus at work, this approach goes beyond a purely workplace lens, reconsidering the established notion that burnout is caused solely by the demands of the workplace.   

While active recovery is critical for reducing stress, a staggering 73 per cent of employees report being unable to schedule regular personal time for themselves. When it comes to household duties, 78 per cent were not splitting responsibilities equally, and 81 per cent do not have a reliable network to help with routine tasks like school drop offs or caregiving.  

Additionally, just one in three (35 per cent) managers believe their organisation recognises and accommodates the needs of working parents and carers and just 29 per cent believe employees feel comfortable raising concerns about bias or discrimination related to family or caring responsibilities. 

Brianna Cattanach, National Manager Mental Health Strategy – Personal Injury, Allianz Australia says, “Allianz is calling on Australian workplaces to take a holistic view of employee wellbeing. Business leaders can support this through job design that ensures; manageable workloads, a natural ebb and flow to work demands, adequate ‘recovery’ time during work hours and ground rules for disconnecting after-hours. 

“This should be accompanied with manager training on how to set these healthy workforce habits, and respond with empathy to work-related burnout and mental distress. This was the most sought after measure that surveyed employees want their organisation to commit to.” 

Helen Lawson Williams, co-founder of anti-burnout program TANK says: “Burnout looks differently, depending on the person, role or industry. But burnout certainly doesn’t have to be part of a job. It can be prevented when teams are checking in with each other on the right things, and taking action early. Employees can start by recognising when their stress / recovery balance is off, which could feel like fatigue, overwhelm, irritability, or caring less about their work than usual.

“Speak up before things escalate, and be specific about what’s making it harder to limit stress or recover well – whether it’s meeting overload, lack of breaks, unrealistic deadlines or inability to focus due to pressures outside the workplace. Ask for what you need, and use the support your workplace offers, like Employee Assistance Program services. Don’t underestimate the power of small changes: taking proper breaks, setting boundaries, and prioritising recovery activities like sleep and exercise can be enough to reset your stress / recovery balance, preventing burnout for good.” 

Visit Allianz’s Unschedule the Burnout Hub at Allianz.com.au/UnscheduleTheBurnout to access the suite of resources.

Eason Technology Limited Received NYSE American Non-Compliance Letter

HONG KONG, Oct. 21, 2025 /PRNewswire/ — Eason Technology Limited (“Eason Technology” or the “Company”) (NYSE: DXF) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE American” or the “Exchange”) on October 14, 2025. The Company is below compliance with Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) since it reported stockholders’ equity of RMB 28 million (approximately USD$3.8 million based on an exchange rate of RMB 7.2993 to US$1.00) as of December 31, 2024, and losses from continuing operations and/or net losses in three of its four most recent fiscal years ended December 31, 2024 (the “Deficiency”). The Company is also not currently eligible for any exemption in Section 1003(a) of the Company Guide from the stockholders’ equity requirements.

The Company is now subject to the procedures and requirements set forth in Section 1009 of the Company Guide. In connection with its Deficiency, the Company must submit a plan by November 13, 2025 (“Plan Due Date”), advising of actions it has taken or will take to regain compliance with the continued listing standards by April 14, 2027 (“Compliance Deadline”).

If the Company does not submit a compliance plan or if the plan is not accepted, delisting proceedings will commence. Furthermore, if the plan is accepted but the Company is not in compliance with the continued listing standards by the Compliance Deadline, or if the Company does not make progress consistent with the plan during the plan period, Exchange staff will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the Company Guide.

This delinquency notice has no immediate impact on the listing of the Company’s ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

About Eason Technology Limited

Eason Technology Limited is a company engaged in real estate operation management and investment and digital technology security business in Hong Kong, China. The Company was formerly a licensed microfinance lender serving individuals and SMEs in Hubei Province, China, but has suspended offering loans to its customers since 2020.

Safe Harbor Statement

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.

Media Contact: 

Mark Xu
ir@dunxin.us

LabConnect Featured in Season Finale of Emmy-Nominated Series Tomorrow’s World Today

JOHNSON CITY, Tenn., Oct. 21, 2025 /PRNewswire/ — LabConnect, a leading provider of global central laboratory and support services for clinical trials, will be featured on the season 9 finale of the innovation-focused TV series, Tomorrow’s World Today. Premiering on Science Channel on November 8, the episode explores how LabConnect is redefining clinical trial support as a technology-first partner for pharma and biotech.

Tomorrow’s World Today is an Emmy-nominated and Telly Award winning series exploring the latest advancements in science, sustainability, innovation, and technology. Airing on Science Channel and Discovery Channel, the show uncovers compelling stories behind transformative ideas and solutions that are redefining how we live, work, and interact with our world.

The LabConnect episode features interviews with Chief Executive Officer Wes Wheeler, Chief Commercial and Strategy Officer Julia Tarasenko, and Chief Technology Officer Charles Castano. Together, they share what makes LabConnect “a lab like no other”, from its global footprint and custom kit-building capabilities to its technology-driven approach that delivers new levels of flexibility, scalability, and efficiency for clinical trials worldwide.

“Clinical research is advancing at an unprecedented pace, and LabConnect is proud to be at the forefront of this transformation,” said Wes Wheeler, CEO of LabConnect. “Our appearance on Tomorrow’s World Today highlights how innovation in lab services can remove barriers, advance discovery, and ultimately bring life-changing therapies to patients faster.”

Tune in on Saturday, November 8 at 10am ET on Science Channel to discover how LabConnect’s innovative, sustainable solutions advance clinical studies of all sizes and complexities with unmatched precision and speed. You can also watch the episode on Discovery Channel on Sunday, November 9 at 8:30am local time or stream the episode on YouTube on November 10.

About LabConnect 
LabConnect is redefining central laboratory services as a technology-driven partner for pharmaceutical and biotechnology companies. Our decentralized network model provides sponsors with access to the industry’s most comprehensive global testing menu, supported by advanced sample tracking, data management, and expert consulting services. With an asset light approach spanning functional service provider solutions, specialty testing, and ancillary support, we deliver scalability and efficiency beyond the limits of traditional laboratory ownership. By building the lab network of the future, LabConnect accelerates the development of life-changing therapies with greater precision, flexibility, and speed. Follow us on LinkedIn and learn more at www.labconnect.com.

About Tomorrow’s World Today
Tomorrow’s World Today is a dynamic series that explores the latest advancements and innovations shaping our world. Featuring knowledgeable experts across various industries, the show delves into a wide array of captivating topics, including sustainable technologies, revolutionary medical breakthroughs, environmental conservation and more. Tomorrow’s World Today goes beyond the surface to uncover the stories behind transformative ideas and solutions that are redefining the way we live, work, and interact with our world. In conjunction with the television show, the Tomorrow’s World Today website serves as an invaluable online resource for those passionate about staying informed on the latest developments in innovation and sustainability. The website features exclusive content, behind-the-scenes insights, in-depth articles, and interviews with thought leaders who are driving positive change across the globe. For more information about Tomorrow’s World Today, please visit tomorrowsworldtoday.com.

Logo – https://laotiantimes.com/wp-content/uploads/2025/10/labconnect_logo.jpg

Blockchain for Good Alliance and UNDP AltFinLab Launch Blockchain Impact Forum

DUBAI, UAE, Oct. 21, 2025 /PRNewswire/ — The Blockchain for Good Alliance (BGA), a flagship non-profit founded by Bybit and championing responsible innovation, together with the United Nations Development Programme (UNDP) AltFinLab, will co-organise the inaugural Blockchain Impact Forum, a pivotal two-day global event designed to unite leaders in advancing blockchain for sustainable and systemic change.

Hosted in Copenhagen, Denmark, on November 4–5, 2025, the Forum is more than another Web3 event; it represents a coalition of global leaders working to match builders with institutional demand for blockchain-based solutions that address real-world challenges.

The invite-only Day 1 will convene policy makers, UN officials, and blockchain pioneers for high-level sessions structured around panels, fireside chats, and in-depth discussions. These contributions will form the foundation of the BGA’s inaugural Impact Report, offering a comprehensive overview of blockchain’s role in driving social good worldwide.

Day 2 opens to the public at T13 Nordhavn in Copenhagen, showcasing the most promising projects from the BGA incubation programme and the SDG Blockchain Accelerator. Attendees will engage in live pitches, interactive networking, and celebrate the Blockchain for Good Awards 2025, recognizing outstanding innovators whose work aligns with the United Nations Sustainable Development Goals (SDGs).

Ben Zhou, CEO of Bybit and Initiator of the Blockchain for Good Alliance underscores his vision for blockchain’s transformative role: “Blockchain for Good is not just an idea; it’s a systems-level shift building bridges between technologists, governments, and communities to achieve the SDGs.”

Co-organised by the Blockchain for Good Alliance and UNDP AltFinLab, the Blockchain Impact Forum establishes a new platform for collaboration between innovators and institutions, reinforcing blockchain’s potential as a driver of sustainable progress.

Day 2 will take place at T13 Nordhavn and culminate with the BGAwards Ceremony, honoring the best players in blockchain for good in 2025, with Bybit EU, GSR Foundation, Xion Foundation, Abu Dhabi Blockchain Center and Mantle Network as title sponsors. FLock.io, Hetu Protocol and Masverse also join as sponsors. Registration for Day 2 is available here.

#Bybit / #CryptoArk / #BGA

Blockchain for Good Alliance and UNDP  AltFinLab Launch Blockchain Impact Forum
Blockchain for Good Alliance and UNDP AltFinLab Launch Blockchain Impact Forum

About Blockchain for Good Alliance (BGA)

The Blockchain for Good Alliance (BGA) is a long-term collaborative non-profit initiative with key partners with the main aim to contribute to societal good by using blockchain technology to solve real world problems. By convening leaders, innovators, and organisations from across the blockchain community, BGA seeks to drive innovation, collaboration, and action towards a more sustainable and equitable world.

For more information
Email: hello@chainforgood.org
Website: www.chainforgood.org 
Twitter: www.x.com/chainforgood 

iVANKY Introduces FusionDock Max 2: The First MacBook Dock for Thunderbolt 5 with Native Triple-Display Support

SHENZHEN, China, Oct. 21, 2025 /PRNewswire/ — iVANKY recently announced FusionDock Max 2, the most advanced MacBook dock for Thunderbolt 5 designed for Apple Silicon users. With native triple-display output, 120 Gbps of bandwidth, and 23 professional-grade ports, it transforms the MacBook into a full desktop-class workstation.

FusionDock Max 2 is the all-in-one MacBook dock for Thunderbolt 5 that truly unlocks the potential of Apple Silicon,” said Alex, Product Director at iVANKY. “It combines triple-display capability, pro-level ports, and stable charging in a design built to perform under heavy load.”

FusionDock Max 2 introduces a dual-chip architecture that pairs a Thunderbolt 5 controller with a DP-Alt chip, allowing users to connect up to two 6K displays and one 4K display natively — a first for MacBook docks. It also unlocks up to 120 Gbps of bandwidth, nearly three times faster than Thunderbolt 4, ensuring smooth performance when editing high-resolution video, moving massive project files, or driving multiple displays at once.

Alongside speed and display power, the dock delivers reliable charging with 140 W for MacBook and an independent 30 W USB-C PD port for accessories. Its 23 ports cover every professional need, from 2.5G Ethernet and SD 4.0 to optical audio and multiple 10 Gbps USB connections. To sustain performance, a hybrid cooling system combines an ultra-quiet fan, suspended chassis design, and copper-alloy midframe, keeping the dock cooler and more stable during heavy workloads.

For creators and power users, the result is a workflow without compromise. Video editors can preview and cut across multiple screens while transferring terabytes of footage. Developers can test, code, and collaborate across different environments seamlessly. Musicians and audio engineers can connect multi-channel gear with minimal latency — all from a single dock built to keep every device powered and every project running smoothly.

FusionDock Max 2 is available now at iVANKY.com and Amazon. Readers can enjoy an exclusive 10% discount with the code PRIORITY10, which can also be applied when purchasing on Amazon.

iVANKY FusionDock Max 2
iVANKY FusionDock Max 2

 

Benchling Partners with Anthropic to Build a Bridge Between Science and AI

Claude’s Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude

SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ — Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling’s trusted data foundation and AI agents with Claude’s advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. Benchling AI agents in Claude handle the heavy-lifting of searching structured data like assay results and molecules and pulling unstructured context buried in lab notebooks, so scientists can focus on analysis and decisions.

 

How scientists are using Benchling AI in Claude today.

Building the AI ecosystem for biotech

AI’s potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could “compress decades of biological progress into just a few years,” opening the door to far better prevention and treatment across diseases. Getting there requires operationalizing AI: pairing advanced models with trustworthy, secure data; purpose-built workflows; and access for every scientist.

“AI in R&D only works through an ecosystem. Anthropic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first,” said Ashu Singhal, Co-founder and President of Benchling. “Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we’re building AI that powers this next chapter of R&D.”

“We’re connecting Claude to the systems science already runs on. With Benchling’s trusted data foundation and AI workflows, Claude helps teams move from research questions to results faster, at lab, program, and portfolio scale,” said Eric Kauderer-Abrams, Head of Life Sciences and Biology, Anthropic.

What scientists can do today

Claude for Life Sciences leverages Benchling as the system of record while Claude synthesizes insights across the data. The integration between Claude and Benchling is possible via Model Context Protocol (MCP), and enables users to move seamlessly between the two, with one-click traceability to the underlying scientific data. Existing permissions and audit logs carry over automatically, so organizations can roll out AI across R&D while maintaining control and compliance.

Here’s how researchers, program leads, bioinformaticians, and scientists are using Benchling in Claude. 

Category

Example prompt

Recommendations

“Based on our last three in vivo results in Benchling and recent FDA guidance, what should we test next?”

Portfolio insights

“Aggregate results from our top five programs and highlight which ones are showing the strongest early efficacy signals compared with industry benchmarks.”

Workflow orchestration

“Pull my Benchling assay results and check for related compound data to see if we’ve already profiled these molecules.”

Cross-source comparison

“Compare the IC50 results from my last two Benchling experiments with recent PubMed articles on AAV stability.”

Multi-tool reporting

“Draft a report that combines Benchling notebook data with statistical analyses to create a single study summary.”

Access and availability

Benchling’s AI agents in the Claude for Life Sciences ecosystem are available to Benchling customers with Benchling AI enabled. Customers should reach out to their account teams for set-up and more information.  

About Benchling
Benchling’s mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups to global biopharmas like Merck, Moderna, and Sanofi. Benchling’s products help scientists capture, connect, and analyze data across the R&D lifecycle. With Benchling AI, scientists use agents and models directly in their workflows, connected to structured data. The result: faster teams, better molecules, and breakthroughs for all.

About Anthropic

Anthropic is an AI research and development company that creates reliable, interpretable, and steerable AI systems. Anthropic’s flagship product is Claude, a large language model trusted by millions of users worldwide. Anthropic’s flagship product is Claude, a family of foundational AI models purpose-built for business tasks. Visit www.anthropic.com for more information.

R&D use cases for Benchling AI in Claude
R&D use cases for Benchling AI in Claude

 

Video – https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4

TraceLink Recognized on Fast Company’s Next Big Things in Tech List

The annual list honors groundbreaking advancements redefining the way we work and live

BOSTON, Oct. 20, 2025 /PRNewswire/ — TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced its inclusion in Fast Company’s Next Big Things in Tech list in the Enduring Impact category. This prestigious recognition highlights emerging technologies that have the potential to profoundly impact industries—from education and sustainability to robotics and artificial intelligence. The Enduring Impact category honors tech breakthroughs from organizations that have been in business for more than 15 years.

For more than 15 years, TraceLink has united the life sciences industry around a single mission: to protect patients by ensuring that critical medicines reach them safely, securely, and on time. Through relentless innovation, TraceLink has evolved from digital Traceability leader to global pioneer in Agentic Orchestration—a new era announced by President and CEO Shabbir Dahod during his keynote at FutureLink Barcelona—in which humans and intelligent agents collaborate to reason, adapt, and act responsibly across the end-to-end supply chain.

“This recognition is not just about technology—it’s about purpose, perseverance, and progress,” said Dahod. “From the very beginning, our focus has been on patients. Today, we’re pioneering an agentic future where humans and digital companions work side-by-side, not to replace people, but to enhance how we deliver high-quality, life-saving products to the world. With OPUS as the agentic orchestration platform backbone that technology teams are using to support their business partners in supply chain, finance, and commercial functions, we’ve built the foundation for a new kind of intelligence—one rooted in real-time information, trust, and human-defined guardrails.”

Building upon the Orchestration Platform for Universal Solutions (OPUS), TraceLink’s breakthroughs in Agentic Orchestration move supply chain operations beyond static systems and brittle automation into adaptive, reasoning-based workflows. This innovation is powered by TraceLink’s unmatched network of more than 339,000 active, pre-integrated links and a foundation of end-to-end, compliant, and secure information sharing across the global pharmaceutical ecosystem.

Dahod added, “There is no AI without information. Real-time, structured data is the bedrock of intelligence. That’s why we built a platform where every transaction, process, and collaboration across the supply chain can be digitalized, understood, and orchestrated—empowering every participant, from manufacturers to pharmacies, to achieve new levels of resilience and efficiency.”

TraceLink’s recent product advancements—including its Multienterprise Information Network Tower (MINT), Process Orchestration for Empowered Teams (POET), and forthcoming Tempo analytics environment—collectively transform the supply chain into a living, learning network where human expertise and agentic intelligence operate in harmony.

The 2025 Next Big Things in Tech honorees represent a diverse array of emerging technologies from established companies, startups, and research organizations. These innovations, while at varying stages of market adoption, share one defining trait: the potential to profoundly reshape industries and improve lives.

“Next Big Things in Tech is both a snapshot of the most interesting tech of the moment and a crystal ball that predicts the next several years,” says Brendan Vaughan, editor-in-chief of Fast Company. “We’re excited to share this list with our readers, and we congratulate the winners for their vision and innovation.”

For more information or to view the complete list of honorees, visit here.

About TraceLink
TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely.

About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

AiMOGA Robotics Unveils 2025 Brand Strategy, Paving a New “Vehicle-Robot Synergy + Global Collaboration” Horizon

WUHU, China, Oct. 20, 2025 /PRNewswire/ — At the AiMOGA Global Business Conference, a new blueprint for embodied intelligence was revealed under the theme “Connecting the World • Incubating the Future.”

Focusing on three pillars—core strategy, technology, and global expansion—AiMOGA Robotics marked a new stage in its embodied AI development. The event gathered partners, media, and experts from over 30 countries to witness how AiMOGA is shaping the future of “Automobile + Humanoid Robot” integration.


01 • New Strategic Vision:

From Automotive Robotics to Trusted Human Assistants

Zhang Guibing, General Manager of AiMOGA Robotics, said the era of embodied intelligence has arrived. Over the past three years, AiMOGA evolved from concept to commercial reality, enabling its humanoid robot Mornine to deliver autonomous presentations, multilingual interaction, and real-world service tasks.

Moving forward, AiMOGA will follow “Practical Technology + Real-world Scenarios + Human Assistants,” advancing vehicle-robot collaboration and expanding humanoid and quadruped products to become a world-leading and trusted AI assistant provider.


02 • Technological Framework Upgrade:

Achieving L3 Core Capability and Launching the “MoNet” Vision-Language Model

Xia Peng, Executive Deputy General Manager, announced AiMOGA’s upgrade from L2 (Collaboration Level) to L3 (Assistance Level), achieving multimodal perception, autonomous execution, and adaptive behavior.

Its “All-domain Intelligent Construction” integrates high-torque joints, 17 DOF dexterous hands, multilingual large model cognition, semantic understanding, and reinforcement learning for autonomous planning.

AiMOGA also founded the Vehicle-Robot Synergy Innovation Center, merging automotive cockpit and robot control expertise, and launched MoNet, a vision-language model for multilingual Q&A and intent analysis.


03 • Global Expansion:

Building an International Sales Network and Charting Bold Future Goals

Leveraging Chery’s 11,000+ outlets, AiMOGA is expanding its global full-scenario delivery.

As the world’s first humanoid robot certified under EU Hardware and Software Certification, AiMOGA has been deployed in 30+ countries, including Malaysia, Indonesia, the UAE, and South Africa.

Partner Nicola noted: “They’re not just machines—they’re reliable assistants.”

By 2030, AiMOGA targets 40,000 humanoid and 90,000 quadruped global shipments across sales, education, and companionship fields.

Conclusion

With clear strategy, advanced technology, and a global ecosystem, AiMOGA Robotics is defining a new era of synergy among humans, robots, and automobiles.